Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $15.5500 (2.64%) ($15.1100 - $15.9000) on Wed. Dec. 14, 2005. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.96% (three month average) | RSI | 75 | Latest Price | $15.5500(2.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.7% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) QQQ(7%) EEM(6%) IWM(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.48% in a week (0% probabilities). SHY(-4%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.48% (StdDev 6.96%) | Hourly BBV | 0 () | Intraday Trend | 2.6% | | | |
|
5 Day Moving Average | $14.96(3.94%) | 10 Day Moving Average | $14.78(5.21%) | 20 Day Moving Average | $13.66(13.84%) | To recent high | -11.9% | To recent low | 72% | Market Cap | $2.743b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |